ctDNA as promising tool for the assessment of minimal residual disease (MRD) and the need of an adjuvant treatment in gastroesophageal adenocarcinoma
暂无分享,去创建一个
M. Fassan | M. De Grandis | S. Murgioni | S. Lonardi | M. Valmasoni | F. Bergamo | R. Alfieri | V. Angerilli | F. Nappo | V. M. Piva | Irene Sole Zuin | S. Ahcene Djaballah | V. Piva | M. D. De Grandis | Vittoria Matilde Piva